Abraxis BioScience Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07* | Dec 98 | |
|---|---|---|---|
| Revenue | 345.3 | 333.7 | 66.5 |
| Cost of Goods Sold | 39.1 | 34.5 | 48.8 |
| Gross Profit | 306.2 | 299.2 | 17.7 |
| Gross Profit Margin | 88.7% | 89.7% | 26.7% |
| SG&A Expense | 274.4 | 230.0 | 13.9 |
| Depreciation & Amortization | 39.4 | 49.1 | -- |
| Operating Income | (278.5) | (49.4) | 0.1 |
| Operating Margin | -- | -- | 0.2% |
| Nonoperating Income | (5.0) | 0.0 | 0.3 |
| Nonoperating Expenses | 18.6 | -- | 1.3 |
| Income Before Taxes | (278.7) | (49.6) | (0.8) |
| Income Taxes | (1.9) | (8.0) | (0.3) |
| Net Income After Taxes | (276.8) | (41.6) | (0.5) |
| Continuing Operations | (276.8) | (41.6) | -- |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (276.8) | (41.6) | -- |
| Total Net Income | (276.8) | (41.6) | (0.5) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (6.91) | (1.04) | -- |
| Dividends per Share | 0.00 | 0.00 | -- |
© 2009 Morningstar, Inc. Financial Data provided by
